vs
KESTRA MEDICAL TECHNOLOGIES, LTD.（KMTS）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
KESTRA MEDICAL TECHNOLOGIES, LTD.的季度营收约是Laird Superfood, Inc.的1.7倍（$22.6M vs $13.3M），Laird Superfood, Inc.净利率更高（-13.2% vs -145.3%，领先132.1%）
Kestra Medical Technologies（KMTS）是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业，核心产品覆盖介入心脏病学与结构性心脏病治疗领域，市场覆盖北美、欧洲及亚太重点区域，服务全球医疗机构与患者。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
KMTS vs LSF — 直观对比
营收规模更大
KMTS
是对方的1.7倍
$13.3M
净利率更高
LSF
高出132.1%
-145.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.6M | $13.3M |
| 净利润 | $-32.8M | $-1.8M |
| 毛利率 | 50.6% | 34.1% |
| 营业利润率 | -140.7% | -13.5% |
| 净利率 | -145.3% | -13.2% |
| 营收同比 | — | 15.0% |
| 净利润同比 | — | -341.4% |
| 每股收益（稀释后） | $-0.64 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KMTSLSF
| Q4 25 | $22.6M | $13.3M | ||
| Q3 25 | $19.4M | $12.9M | ||
| Q2 25 | — | $12.0M | ||
| Q1 25 | — | $11.7M | ||
| Q4 24 | — | $11.6M | ||
| Q3 24 | — | $11.8M | ||
| Q2 24 | — | $10.0M | ||
| Q1 24 | — | $9.9M |
净利润KMTSLSF
| Q4 25 | $-32.8M | $-1.8M | ||
| Q3 25 | $-25.8M | $-975.1K | ||
| Q2 25 | — | $-362.2K | ||
| Q1 25 | — | $-156.2K | ||
| Q4 24 | — | $-398.4K | ||
| Q3 24 | — | $-166.1K | ||
| Q2 24 | — | $-239.1K | ||
| Q1 24 | — | $-1.0M |
毛利率KMTSLSF
| Q4 25 | 50.6% | 34.1% | ||
| Q3 25 | 45.7% | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
营业利润率KMTSLSF
| Q4 25 | -140.7% | -13.5% | ||
| Q3 25 | -149.1% | -7.7% | ||
| Q2 25 | — | -3.3% | ||
| Q1 25 | — | -1.9% | ||
| Q4 24 | — | -4.1% | ||
| Q3 24 | — | -2.3% | ||
| Q2 24 | — | -3.4% | ||
| Q1 24 | — | -11.0% |
净利率KMTSLSF
| Q4 25 | -145.3% | -13.2% | ||
| Q3 25 | -133.3% | -7.6% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | — | -1.4% | ||
| Q2 24 | — | -2.4% | ||
| Q1 24 | — | -10.3% |
每股收益（稀释后）KMTSLSF
| Q4 25 | $-0.64 | — | ||
| Q3 25 | $-0.50 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $175.4M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $164.1M | $11.5M |
| 总资产 | $246.7M | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KMTSLSF
| Q4 25 | $175.4M | $5.1M | ||
| Q3 25 | $201.2M | $5.1M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | — | $8.3M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | — | $7.6M | ||
| Q1 24 | — | $7.1M |
股东权益KMTSLSF
| Q4 25 | $164.1M | $11.5M | ||
| Q3 25 | $184.2M | $12.8M | ||
| Q2 25 | — | $13.4M | ||
| Q1 25 | — | $13.3M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | — | $13.1M | ||
| Q2 24 | — | $12.6M | ||
| Q1 24 | — | $12.7M |
总资产KMTSLSF
| Q4 25 | $246.7M | $19.2M | ||
| Q3 25 | $266.3M | $18.9M | ||
| Q2 25 | — | $20.4M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $18.8M | ||
| Q2 24 | — | $18.0M | ||
| Q1 24 | — | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.3M | $68.4K |
| 自由现金流经营现金流 - 资本支出 | $-25.6M | — |
| 自由现金流率自由现金流/营收 | -113.5% | — |
| 资本支出强度资本支出/营收 | 32.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KMTSLSF
| Q4 25 | $-18.3M | $68.4K | ||
| Q3 25 | $-26.3M | $1.2M | ||
| Q2 25 | — | $-2.8M | ||
| Q1 25 | — | $-1.3M | ||
| Q4 24 | — | $339.2K | ||
| Q3 24 | — | $305.8K | ||
| Q2 24 | — | $642.7K | ||
| Q1 24 | — | $-422.3K |
自由现金流KMTSLSF
| Q4 25 | $-25.6M | — | ||
| Q3 25 | $-34.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率KMTSLSF
| Q4 25 | -113.5% | — | ||
| Q3 25 | -177.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度KMTSLSF
| Q4 25 | 32.2% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KMTS
暂无分部数据
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
